Asthma is a chronic inflammatory disorder of the airways, characterized by hyperresponsiveness, airflow obstruction, and recurrent respiratory symptoms. Despite advancements in pharmacological treatments, current therapies often have side effects and show variable effectiveness, underscoring the need for safer and more effective alternatives. Pistacia integerrima J.L. Stewart ex Brandis, commonly known as Kakarsinghi, has traditionally been used in South Asia to treat respiratory conditions, including cough, bronchitis, and asthma. This practice is prevalent in Ayurveda, Unani medicine, and local folklore. Phytochemical studies have identified various bioactive compounds in Kakarsinghi, including flavonoids, terpenoids, and phenolic acids, which exhibit antioxidant, anti-inflammatory, immunomodulatory, and bronchodilatory properties. Preclinical research demonstrates that P. integerrima extracts and isolated constituents can modulate key molecular pathways associated with asthma pathophysiology, including the inhibition of NF-κB, suppression of inducible nitric oxide synthase, modulation of mast cell stabilization, and downregulation of Th2 cytokines such as IL-4, IL-5, and IL-13. Clinical studies indicate that galls may effectively prevent respiratory attacks and enhance chest expansion and respiratory rate when used in poly-herbal formulations. These findings support the traditional use of galls and suggest their potential as an adjunct therapy. This review speculates on the available data, comprising ethnobotany, phytochemistry, pharmacology, and multifaceted therapeutic prospects of P. integerrima, highlighting its potential role as a natural intervention for asthma.
哮喘是一种气道慢性炎症性疾病,以高反应性、气流阻塞和反复出现呼吸道症状为特征。尽管药物治疗取得了进步,但目前的治疗方法往往有副作用,而且效果不一,因此需要更安全、更有效的替代方法。黄连木J.L. Stewart ex Brandis,俗称Kakarsinghi,在南亚传统上用于治疗呼吸系统疾病,包括咳嗽、支气管炎和哮喘。这种做法在阿育吠陀、乌纳尼医学和当地民间传说中很普遍。植物化学研究已经鉴定出kakarsingi中的各种生物活性化合物,包括黄酮类化合物、萜类化合物和酚酸,它们具有抗氧化、抗炎、免疫调节和支气管扩张的特性。临床前研究表明,整枝草提取物和分离成分可以调节哮喘病理生理相关的关键分子通路,包括抑制NF-κB、抑制诱导型一氧化氮合酶、调节肥大细胞稳定性、下调Th2细胞因子如IL-4、IL-5和IL-13。临床研究表明,在多草药配方中使用,可以有效地预防呼吸疾病,增强胸部扩张和呼吸频率。这些发现支持了传统的胆囊疗法,并提示其作为辅助疗法的潜力。这篇综述推测了现有的数据,包括民族植物学,植物化学,药理学和多方面的治疗前景,强调了其作为哮喘自然干预的潜在作用。
{"title":"A multi-faceted pharmacology of <i>Pistacia Integerrima</i> mitigating asthma: a review on ethnopharmacology, phytochemicals, mechanisms, and formulations.","authors":"Aditi Sharma, Md Abubakar, Rashi Yadav, S Sarika, Rohit Sharma, Uma Ranjan Lal, Vijay Kumar Kapoor, Sachchida Nand Rai, Nitesh Kumar, Rohit Goyal","doi":"10.1007/s13205-025-04664-0","DOIUrl":"https://doi.org/10.1007/s13205-025-04664-0","url":null,"abstract":"<p><p>Asthma is a chronic inflammatory disorder of the airways, characterized by hyperresponsiveness, airflow obstruction, and recurrent respiratory symptoms. Despite advancements in pharmacological treatments, current therapies often have side effects and show variable effectiveness, underscoring the need for safer and more effective alternatives. <i>Pistacia integerrima</i> J.L. Stewart ex Brandis, commonly known as Kakarsinghi, has traditionally been used in South Asia to treat respiratory conditions, including cough, bronchitis, and asthma. This practice is prevalent in Ayurveda, Unani medicine, and local folklore. Phytochemical studies have identified various bioactive compounds in Kakarsinghi, including flavonoids, terpenoids, and phenolic acids, which exhibit antioxidant, anti-inflammatory, immunomodulatory, and bronchodilatory properties. Preclinical research demonstrates that <i>P. integerrima</i> extracts and isolated constituents can modulate key molecular pathways associated with asthma pathophysiology, including the inhibition of NF-κB, suppression of inducible nitric oxide synthase, modulation of mast cell stabilization, and downregulation of Th2 cytokines such as IL-4, IL-5, and IL-13. Clinical studies indicate that galls may effectively prevent respiratory attacks and enhance chest expansion and respiratory rate when used in poly-herbal formulations. These findings support the traditional use of galls and suggest their potential as an adjunct therapy. This review speculates on the available data, comprising ethnobotany, phytochemistry, pharmacology, and multifaceted therapeutic prospects of <i>P. integerrima</i>, highlighting its potential role as a natural intervention for asthma.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"61"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-29DOI: 10.1007/s13205-025-04657-z
Eetika Chot, M Vasundhara, Krishna Mohan Medicherla, M Sudhakara Reddy
Taxol (paclitaxel) is a widely used anticancer drug with a complex biosynthetic pathway that has puzzled biochemists for decades. The endophytic fungus Fusarium tricinctum T6 isolated from the bark of Taxus baccata comprises potential anticancer and antioxidant activities. In the present study, the fungal extract profiling using the UHPLC-ESI-MS/MS technique confirmed the Taxol production from F. tricinctum T6 strain. The study further addressed the long-standing challenge of uncovering the fungal Taxol biosynthesis genes and pathway. In genome-wide sequence analysis, among 13,249 predicted gene models, 8 associated with the mevalonate pathway and 19 other Taxol biosynthesis genes were determined, whereas no single 2-C-methyl-D-erythritol 4-phosphate pathway-related gene was found. The identified fungal Taxol biosynthesis genes are mainly homologous to those in Taxus and other plant species, with low percentage identities. Contrary to past studies, the conserved "DXDD" motif was observed in predicted taxa-4(5),11(12)-diene synthase of F. tricinctum and Pestalotiopsis microspora. Notably, despite the low sequence identities between F. tricinctum and Taxus brevifolia taxa-4(5),11(12)-diene synthase, the remarkable structural similarity of their active sites indicates likely conservation of enzymatic function. The study revealed the Taxol production and sole involvement of the mevalonate pathway in the biosynthesis of Taxol precursors, while supporting the potential independent origin of the Taxol biosynthesis pathway in F. tricinctum from the host plants. This work also provides an understanding of Taxol biosynthesis and establishes a foundation for its biotechnological production.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04657-z.
紫杉醇(紫杉醇)是一种广泛应用的抗癌药物,其复杂的生物合成途径困扰了生物化学家几十年。从红豆杉(Taxus baccata)树皮中分离到的内生真菌镰刀菌(Fusarium tricinctum T6)具有潜在的抗癌和抗氧化活性。本研究采用UHPLC-ESI-MS/MS技术对真菌提取物进行分析,证实了F. tricinctum T6菌株产紫杉醇。该研究进一步解决了揭示真菌紫杉醇生物合成基因和途径的长期挑战。在全基因组序列分析中,在13249个预测基因模型中,确定了8个与甲羟戊酸途径相关的基因和19个其他紫杉醇生物合成基因,而没有发现单个2- c -甲基- d -赤藓糖醇4-磷酸途径相关的基因。鉴定的真菌紫杉醇生物合成基因主要与红豆杉属和其他植物同源,同源率较低。与以往的研究相反,在预测的F. tricinctum和拟盘多毛孢(pstalotiopsis microspora)的4(5)、11(12)-二烯合成酶中发现了保守的“DXDD”基序。值得注意的是,尽管三角红豆杉和短叶红豆杉类群-4(5),11(12)-二烯合成酶的序列同源性较低,但其活性位点的显著结构相似性表明可能存在酶功能的保守性。该研究揭示了紫杉醇的产生和甲羟戊酸途径单独参与了紫杉醇前体的生物合成,同时支持了紫杉醇生物合成途径可能来自寄主植物的独立来源。本研究为紫杉醇的生物合成提供了新的认识,并为其生物技术生产奠定了基础。补充信息:在线版本包含补充资料,下载地址:10.1007/s13205-025-04657-z。
{"title":"Taxol production and Elucidation of its biosynthetic pathway in endophytic fungus <i>Fusarium tricinctum</i> associated with <i>Taxus baccata</i>.","authors":"Eetika Chot, M Vasundhara, Krishna Mohan Medicherla, M Sudhakara Reddy","doi":"10.1007/s13205-025-04657-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04657-z","url":null,"abstract":"<p><p>Taxol (paclitaxel) is a widely used anticancer drug with a complex biosynthetic pathway that has puzzled biochemists for decades. The endophytic fungus <i>Fusarium tricinctum</i> T6 isolated from the bark of <i>Taxus baccata</i> comprises potential anticancer and antioxidant activities. In the present study, the fungal extract profiling using the UHPLC-ESI-MS/MS technique confirmed the Taxol production from <i>F. tricinctum</i> T6 strain. The study further addressed the long-standing challenge of uncovering the fungal Taxol biosynthesis genes and pathway. In genome-wide sequence analysis, among 13,249 predicted gene models, 8 associated with the mevalonate pathway and 19 other Taxol biosynthesis genes were determined, whereas no single 2-C-methyl-D-erythritol 4-phosphate pathway-related gene was found. The identified fungal Taxol biosynthesis genes are mainly homologous to those in <i>Taxus</i> and other plant species, with low percentage identities. Contrary to past studies, the conserved \"DXDD\" motif was observed in predicted taxa-4(5),11(12)-diene synthase of <i>F. tricinctum</i> and <i>Pestalotiopsis microspora.</i> Notably, despite the low sequence identities between <i>F. tricinctum</i> and <i>Taxus brevifolia</i> taxa-4(5),11(12)-diene synthase, the remarkable structural similarity of their active sites indicates likely conservation of enzymatic function. The study revealed the Taxol production and sole involvement of the mevalonate pathway in the biosynthesis of Taxol precursors, while supporting the potential independent origin of the Taxol biosynthesis pathway in <i>F. tricinctum</i> from the host plants. This work also provides an understanding of Taxol biosynthesis and establishes a foundation for its biotechnological production.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04657-z.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"39"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145861763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Soybean plants showing the symptoms of veinal necrosis and bud blight were examined to identify the associated viral agent. Transmission electron microscopy revealed the flexuous and filamentous virus particles. DAC-ELISA of symptomatic samples confirmed the presence of cowpea mild mottle virus (CPMMV) while other tested viruses GBNV, SMV, SVNV, TSV and TRSV were found to be absent. RT-PCR using CPMMV coat protein (CP) gene primers consistently produced an 867-bp amplicon, whereas amplification was not observed for other viruses confirming its association with the disease. Sequence analysis of the CPMMV CP gene showed 99% similarity with Indian urdbean isolate (MH345698) followed by other CPMMV isolates (89-98%) and clustered phylogenetically distinct from Brazil, China and Ghana isolates. Mechanical sap inoculation resulted in 30-60% transmission efficiency across host species. Nicotiana benthamiana exhibited severe systemic infection and seedling wilting, indicating high susceptibility. Cowpea and French bean developed systemic chlorosis and necrosis, while soybean genotypes showed restricted symptoms. DAC-ELISA, RT-PCR and RT-qPCR confirmed CPMMV infection, with viral copy numbers ranging from 8.54 × 10⁵ to 5.7 × 10⁸ in field-collected soybean and 4.7 × 10⁸ in N. benthamiana. Cowpea and French bean accumulated moderate viral loads, whereas soybean genotypes Pusa-12 and PS-1670 supported limited replication. No other viruses were detected. These results conclusively establish CPMMV as the causal agent of veinal necrosis and bud blight disease in soybean and demonstrate its differential infectivity and accumulation across host species.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04640-8.
{"title":"<i>Cowpea mild mottle virus</i> (<i>Carlavirus vignae</i>) identified as one of the agents associated with veinal necrosis and bud blight disease in soybean (<i>Glycine max</i> L.) in India.","authors":"Nagamani Sandra, Ankita Tripathi, Dhruva Nitin Bhagwatkar, Garima Dalal, Sharankumar Kesaratagi, Manisha Saini, Sanjay Kumar Lal","doi":"10.1007/s13205-025-04640-8","DOIUrl":"https://doi.org/10.1007/s13205-025-04640-8","url":null,"abstract":"<p><p>Soybean plants showing the symptoms of veinal necrosis and bud blight were examined to identify the associated viral agent. Transmission electron microscopy revealed the flexuous and filamentous virus particles. DAC-ELISA of symptomatic samples confirmed the presence of cowpea mild mottle virus (CPMMV) while other tested viruses GBNV, SMV, SVNV, TSV and TRSV were found to be absent. RT-PCR using CPMMV coat protein (CP) gene primers consistently produced an 867-bp amplicon, whereas amplification was not observed for other viruses confirming its association with the disease. Sequence analysis of the CPMMV CP gene showed 99% similarity with Indian urdbean isolate (MH345698) followed by other CPMMV isolates (89-98%) and clustered phylogenetically distinct from Brazil, China and Ghana isolates. Mechanical sap inoculation resulted in 30-60% transmission efficiency across host species. <i>Nicotiana benthamiana</i> exhibited severe systemic infection and seedling wilting, indicating high susceptibility. Cowpea and French bean developed systemic chlorosis and necrosis, while soybean genotypes showed restricted symptoms. DAC-ELISA, RT-PCR and RT-qPCR confirmed CPMMV infection, with viral copy numbers ranging from 8.54 × 10⁵ to 5.7 × 10⁸ in field-collected soybean and 4.7 × 10⁸ in <i>N. benthamiana</i>. Cowpea and French bean accumulated moderate viral loads, whereas soybean genotypes Pusa-12 and PS-1670 supported limited replication. No other viruses were detected. These results conclusively establish CPMMV as the causal agent of veinal necrosis and bud blight disease in soybean and demonstrate its differential infectivity and accumulation across host species.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04640-8.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"43"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aging process is associated with gradual cognitive decline resulting from deficits in synaptic plasticity, the brain's natural ability to adapt and reshape its neural circuitry. This review highlights the importance of synaptic plasticity in cognitive function. It provides a full overview of the molecular, cellular, and systemic mechanisms involved in enhanced or diminished synaptic plasticity in the aging brain. We also go over issues in neurotransmitter systems, calcium signaling, neurotrophic support (ex., BDNF-TrkB), cellular signaling pathways (e.g. mTOR, CaMK, CREB, and MAPK/ERK), and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. Therapeutic approaches toward increasing or restoring synaptic plasticity are evaluated, including pharmacological (e.g., nootropics, cholinesterase inhibitors, NMDA receptor modulators), natural (e.g., curcumin, resveratrol, bacoside A), and new interventions (e.g., psychoplastogens, gene therapy, nanocarriers, and digital therapeutics). Lifestyle approaches, especially physical exercise, cognitive training, intermittent fasting, and mindfulness approaches to stimulation, have highly potent effects on plasticity enhancements and employ multiple neurobiological mechanisms. Despite much promise, there remain substantial translational challenges, including limited clinical efficacy, lack of personalized biomarkers, and ethical considerations concerning cognitive enhancement. As we look ahead, a multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals. This review highlights the immediate necessity for personalized, ethical, and evidence-based approaches to take advantage of synaptic plasticity for healthy cognitive aging.
{"title":"Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.","authors":"Falguni Goel, Payal Singh, Sachchida Nand Rai, Dharmendra Kumar Yadav","doi":"10.1007/s13205-025-04673-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04673-z","url":null,"abstract":"<p><p>The aging process is associated with gradual cognitive decline resulting from deficits in synaptic plasticity, the brain's natural ability to adapt and reshape its neural circuitry. This review highlights the importance of synaptic plasticity in cognitive function. It provides a full overview of the molecular, cellular, and systemic mechanisms involved in enhanced or diminished synaptic plasticity in the aging brain. We also go over issues in neurotransmitter systems, calcium signaling, neurotrophic support (ex., BDNF-TrkB), cellular signaling pathways (e.g. mTOR, CaMK, CREB, and MAPK/ERK), and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. Therapeutic approaches toward increasing or restoring synaptic plasticity are evaluated, including pharmacological (e.g., nootropics, cholinesterase inhibitors, NMDA receptor modulators), natural (e.g., curcumin, resveratrol, bacoside A), and new interventions (e.g., psychoplastogens, gene therapy, nanocarriers, and digital therapeutics). Lifestyle approaches, especially physical exercise, cognitive training, intermittent fasting, and mindfulness approaches to stimulation, have highly potent effects on plasticity enhancements and employ multiple neurobiological mechanisms. Despite much promise, there remain substantial translational challenges, including limited clinical efficacy, lack of personalized biomarkers, and ethical considerations concerning cognitive enhancement. As we look ahead, a multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals. This review highlights the immediate necessity for personalized, ethical, and evidence-based approaches to take advantage of synaptic plasticity for healthy cognitive aging.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"64"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-08DOI: 10.1007/s13205-025-04637-3
Sushil Kumar, Amar A Sakure, Hensi Kundaria, Mukesh P Patel, Rumit Patel, Pankaj Katba, Kaplesh Patel
Castor (Ricinus communis L.) in Euphorbiaceae family is an important tropical crop cultivated for seeds containing industrially valuable oil. With economic development, demand for castor beans and oil is rapidly increasing, yet production is severely affected by fungal diseases, particularly Fusarium and Macrophomina, due to limited advanced breeding methods. F. oxysporum f. sp. ricini -induced wilt in castor is a major pathogenic factor responsible for severe yield losses. Wilt resistance, a complex trait controlled by quantitative trait loci (QTLs), was investigated in this study by developing a linkage map and identifying novel QTLs in castor using F2:3 population. The was developed from the cross between two castor inbred lines, 48 - 1 (Jwala) and the wilt-susceptible genotype JI-35, and screened under pot conditions. Linkage map was developed using 71 SSR markers. A genetic map comprising 13 linkage groups, spanning a total of 1,028.7 cM centimorgans (cM). Analysis of genotypic and phenotypic data from the mapping population, evaluated for wilt in pots, identified two QTLs on LG1 and 6 explaining 12.44-16.58% of phenotypic variation. PCR amplification using linked markers on LG 1 in resistant and susceptible F₄ families of the mapping population demonstrated that these markers effectively distinguish plants resistant or susceptible to wilt disease. These markers can be utilized for developing resistant varieties via backcross breeding and for screening germplasm at the seedling stage.
蓖麻(Ricinus communis L.)是大戟科的一种重要的热带作物,其种子含有工业价值油。随着经济的发展,对蓖麻豆和蓖麻油的需求迅速增加,但由于先进的育种方法有限,生产受到真菌病害的严重影响,特别是镰刀菌和巨镰刀菌。蓖麻枯萎病是造成蓖麻产量严重损失的主要致病因素。本研究以蓖麻F2:3群体为研究对象,建立了蓖麻抗黄萎病的连锁图谱,并鉴定了新的qtl。以蓖麻48 - 1 (Jwala)和JI-35为亲本,在盆栽条件下进行筛选。利用71个SSR标记构建连锁图谱。由13个连锁群组成的遗传图谱,共跨越1028.7 cM cM。对定位群体的基因型和表型数据进行分析,鉴定出LG1和lg6上的两个qtl,解释了12.44-16.58%的表型变异。利用f4抗性和易感家族的LG 1连锁标记进行PCR扩增,结果表明这些标记可以有效区分植物对枯萎病的抗性和易感性。这些标记可用于回交选育抗性品种和苗期种质筛选。
{"title":"Development of linkage map and mapping of SSR markers linked to fusarium wilt resistance in F<sub>2:3</sub> population of castor (<i>Ricinus communis</i> L.).","authors":"Sushil Kumar, Amar A Sakure, Hensi Kundaria, Mukesh P Patel, Rumit Patel, Pankaj Katba, Kaplesh Patel","doi":"10.1007/s13205-025-04637-3","DOIUrl":"https://doi.org/10.1007/s13205-025-04637-3","url":null,"abstract":"<p><p>Castor (<i>Ricinus communis</i> L.) in Euphorbiaceae family is an important tropical crop cultivated for seeds containing industrially valuable oil. With economic development, demand for castor beans and oil is rapidly increasing, yet production is severely affected by fungal diseases, particularly <i>Fusarium</i> and <i>Macrophomina</i>, due to limited advanced breeding methods. <i>F. oxysporum</i> f. sp. <i>ricini</i> -induced wilt in castor is a major pathogenic factor responsible for severe yield losses. Wilt resistance, a complex trait controlled by quantitative trait loci (QTLs), was investigated in this study by developing a linkage map and identifying novel QTLs in castor using F2:3 population. The was developed from the cross between two castor inbred lines, 48 - 1 (Jwala) and the wilt-susceptible genotype JI-35, and screened under pot conditions. Linkage map was developed using 71 SSR markers. A genetic map comprising 13 linkage groups, spanning a total of 1,028.7 cM centimorgans (cM). Analysis of genotypic and phenotypic data from the mapping population, evaluated for wilt in pots, identified two QTLs on LG1 and 6 explaining 12.44-16.58% of phenotypic variation. PCR amplification using linked markers on LG 1 in resistant and susceptible F₄ families of the mapping population demonstrated that these markers effectively distinguish plants resistant or susceptible to wilt disease. These markers can be utilized for developing resistant varieties via backcross breeding and for screening germplasm at the seedling stage.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"25"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Quercetin (QR), a plant-derived flavonoid, was evaluated as an adjuvant to enhance ciprofloxacin (CP) and tetracycline (TE) efficacy against Vibrio cholerae O1 El Tor (C6706) and non-O1/non-O139 (SC134) strains. Checkerboard assays revealed additive effects (FICI = 0.75) for QR+CP and QR+TE against both strains, with synergy (FICI = 0.5) for QR+TE in C6706. QR-antibiotic combinations significantly increased membrane permeability (by 162-188% in C6706 and 151-189% in SC134) and intracellular reactive oxygen species (ROS) generation (by 229-262% in C6706 and 211-241% in SC134), potentiating antibiotic-induced bacterial death. Sub-MIC combinations markedly inhibited biofilm formation (67-76%) and reduced viable biofilm cells (CFU counts), supported by crystal violet (CV) and FESEM imaging. QR and antibiotics at higher doses (multiple MICs) eradicated preformed biofilms (77-79% in C6706; 40-43% in SC134). Quantitative assays confirmed significant reductions in biofilm matrix components, exopolysaccharides (73-82%), proteins (59-67%), and extracellular DNA (79-92%). QR also decreased cell surface hydrophobicity, induced morphological elongation, and impaired adhesion. Furthermore, QR combinations significantly suppressed swimming motility and protease activity, indicating attenuation of virulence. In silico docking showed strong binding of QR-antibiotic complexes to key regulatory proteins governing biofilm (VpsR, RbmA, Bap1), virulence (LuxO, AphA), and morphology (CrvA), suggesting targeted pathway interference. Collectively, these findings demonstrate that QR enhances the antibacterial, antibiofilm, and antivirulence efficacy of CP and TE against V. cholerae through multi-mechanistic modulation of membrane permeability, oxidative stress, and virulence regulation, supporting its potential as an effective antibiotic adjuvant.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04621-x.
槲皮素(QR)是一种植物衍生的类黄酮,可作为辅助剂增强环丙沙星(CP)和四环素(TE)对霍乱弧菌O1 El Tor (C6706)和非O1/非o139 (SC134)菌株的治疗效果。棋盘试验结果显示,QR+CP和QR+TE对C6706的加性效应(FICI = 0.75)和协同效应(FICI = 0.5)。qr -抗生素组合显著增加了膜通透性(C6706为162-188%,SC134为151-189%)和细胞内活性氧(ROS)的产生(C6706为229-262%,SC134为211-241%),增强了抗生素诱导的细菌死亡。亚mic组合显著抑制了生物膜的形成(67-76%),并减少了活的生物膜细胞(CFU计数),这得到了结晶紫(CV)和FESEM成像的支持。QR和高剂量抗生素(多个mic)可根除预成型生物膜(C6706为77-79%,SC134为40-43%)。定量分析证实生物膜基质成分、胞外多糖(73-82%)、蛋白质(59-67%)和细胞外DNA(79-92%)显著减少。QR还降低了细胞表面的疏水性,诱导了形态延伸,并损害了粘附。此外,QR组合显著抑制游泳运动和蛋白酶活性,表明毒力减弱。硅对接显示,qr -抗生素复合物与控制生物膜的关键调控蛋白(VpsR、RbmA、Bap1)、毒力(LuxO、AphA)和形态(CrvA)有很强的结合,提示有针对性的通路干扰。总之,这些发现表明,QR通过多机制调节膜通透性、氧化应激和毒力调节,增强了CP和TE对霍乱弧菌的抗菌、抗生物膜和抗毒力,支持其作为有效抗生素佐剂的潜力。补充信息:在线版本包含补充资料,提供地址为10.1007/s13205-025-04621-x。
{"title":"Quercetin as an additive adjuvant enhances ciprofloxacin and tetracycline efficacy against <i>Vibrio cholerae</i> by disrupting membranes, inhibiting biofilms, and reducing virulence levels.","authors":"Suman Paul, Argajit Sarkar, Manisha Ghosh, Debajyoti Datta, Moumita Debnath, Surajit Basak, Saumya Raychaudhuri, Surajit Bhattacharjee","doi":"10.1007/s13205-025-04621-x","DOIUrl":"https://doi.org/10.1007/s13205-025-04621-x","url":null,"abstract":"<p><p>Quercetin (QR), a plant-derived flavonoid, was evaluated as an adjuvant to enhance ciprofloxacin (CP) and tetracycline (TE) efficacy against <i>Vibrio cholerae</i> O1 El Tor (C6706) and non-O1/non-O139 (SC134) strains. Checkerboard assays revealed additive effects (FICI = 0.75) for QR+CP and QR+TE against both strains, with synergy (FICI = 0.5) for QR+TE in C6706. QR-antibiotic combinations significantly increased membrane permeability (by 162-188% in C6706 and 151-189% in SC134) and intracellular reactive oxygen species (ROS) generation (by 229-262% in C6706 and 211-241% in SC134), potentiating antibiotic-induced bacterial death. Sub-MIC combinations markedly inhibited biofilm formation (67-76%) and reduced viable biofilm cells (CFU counts), supported by crystal violet (CV) and FESEM imaging. QR and antibiotics at higher doses (multiple MICs) eradicated preformed biofilms (77-79% in C6706; 40-43% in SC134). Quantitative assays confirmed significant reductions in biofilm matrix components, exopolysaccharides (73-82%), proteins (59-67%), and extracellular DNA (79-92%). QR also decreased cell surface hydrophobicity, induced morphological elongation, and impaired adhesion. Furthermore, QR combinations significantly suppressed swimming motility and protease activity, indicating attenuation of virulence. In silico docking showed strong binding of QR-antibiotic complexes to key regulatory proteins governing biofilm (VpsR, RbmA, Bap1), virulence (LuxO, AphA), and morphology (CrvA), suggesting targeted pathway interference. Collectively, these findings demonstrate that QR enhances the antibacterial, antibiofilm, and antivirulence efficacy of CP and TE against <i>V. cholerae</i> through multi-mechanistic modulation of membrane permeability, oxidative stress, and virulence regulation, supporting its potential as an effective antibiotic adjuvant.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04621-x.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"3"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12669460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145666719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-20DOI: 10.1007/s13205-025-04651-5
Talha Bin Emran, Md Al Amin, Safia Obaidur Rab, Patibandla Jahnavi, Rajeshwar Vodeti, Jeetendra Kumar Gupta, Uppuluri Varuna Naga Venkata Arjun, T N Umamaheswari, P Balaji, Girija Dayalan, Soniya Rani, Prem Shankar Gupta
The tumor microenvironment (TME) significantly impacts tumor development, metastasis, immune evasion, and resistance to conventional treatments. Recent nanomedicine advancements aid the formation of intelligent, multipurpose nanosystems that precisely target and modify various TME elements, including hypoxia, extracellular matrix, tumor-associated macrophages, and immunological checkpoints. The review highlights recent advancements in nanotechnology-based methods for optimizing medication delivery, renewing the TME, and enhancing treatment outcomes. It discusses the impact of nanomedicines on the TME, including immune modulation, stimuli-responsive drug release, and the restoration of abnormal vasculature. It also demonstrates the translational landscape of these methods, focusing on safety profiles, clinical trials, and scaling challenges from preclinical models to clinical applications. Nanomedicine offers personalized cancer treatments by regulating tumor TME, enhancing immunity, restoring tumor vasculature, and targeting multiple TME components through smart nanocarriers. Combination approaches with immunotherapy, photothermal therapy, and chemotherapy show synergistic results. Clinical trials show promise but face scalability and reproducibility issues.
{"title":"Advances in nanomedicine strategies for modulating the tumor microenvironment: Recent progress and clinical perspectives.","authors":"Talha Bin Emran, Md Al Amin, Safia Obaidur Rab, Patibandla Jahnavi, Rajeshwar Vodeti, Jeetendra Kumar Gupta, Uppuluri Varuna Naga Venkata Arjun, T N Umamaheswari, P Balaji, Girija Dayalan, Soniya Rani, Prem Shankar Gupta","doi":"10.1007/s13205-025-04651-5","DOIUrl":"https://doi.org/10.1007/s13205-025-04651-5","url":null,"abstract":"<p><p>The tumor microenvironment (TME) significantly impacts tumor development, metastasis, immune evasion, and resistance to conventional treatments. Recent nanomedicine advancements aid the formation of intelligent, multipurpose nanosystems that precisely target and modify various TME elements, including hypoxia, extracellular matrix, tumor-associated macrophages, and immunological checkpoints. The review highlights recent advancements in nanotechnology-based methods for optimizing medication delivery, renewing the TME, and enhancing treatment outcomes. It discusses the impact of nanomedicines on the TME, including immune modulation, stimuli-responsive drug release, and the restoration of abnormal vasculature. It also demonstrates the translational landscape of these methods, focusing on safety profiles, clinical trials, and scaling challenges from preclinical models to clinical applications. Nanomedicine offers personalized cancer treatments by regulating tumor TME, enhancing immunity, restoring tumor vasculature, and targeting multiple TME components through smart nanocarriers. Combination approaches with immunotherapy, photothermal therapy, and chemotherapy show synergistic results. Clinical trials show promise but face scalability and reproducibility issues.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"36"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The blast disease of rice is caused by a well-known pathogen Magnaporthe oryzae infecting the rice crop in all growth stages and results in devastating yield losses. Due to the complex polyphyletic lineage of the pathogen population and the existence of numerous transposable elements, understanding its genetic diversity is essential for effective disease management. The present study aims to minimize the rapid breakdown of disease resistance and in a way that limit the emergence of new races. Virulence screening on a set of rice differentials revealed the presence of 18 International races collected from various cultivars across three agroclimatic zones of Telangana, India. Further, 40 single spore isolates of M. oryzae were characterized using PCR-based genetic techniques such as RAPD, SSR, and Pot2-TIR. Notably, Lineage - I identified through Pot2 - TIR analysis contained the largest number of isolates, while other lineages represent smaller numbers of isolates. In broader terms, each lineage included isolates with different geographic origins, cultivars and diseased plant parts and there was no discernible relationship between pathotypes and DNA fingerprinting. Having been contemplated, these findings demonstrated that the M. oryzae population collected from various rice cultivars grown in Telangana had greater individual diversity than population diversity. Hence, for efficient disease management, use of certified seed and removal of collateral hosts are recommended.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04610-0.
{"title":"Divulging the variability of rice blast pathogen (<i>Magnaporthe oryzae</i>) population, in Telangana, India.","authors":"Emani Rajeswari, Bokka VidyaSagar, Madamsetty Srinivas Prasad, Budala Teja Bhushan, Karni Aravind, Vikraman Muniyandi","doi":"10.1007/s13205-025-04610-0","DOIUrl":"https://doi.org/10.1007/s13205-025-04610-0","url":null,"abstract":"<p><p>The blast disease of rice is caused by a well-known pathogen <i>Magnaporthe oryzae</i> infecting the rice crop in all growth stages and results in devastating yield losses. Due to the complex polyphyletic lineage of the pathogen population and the existence of numerous transposable elements, understanding its genetic diversity is essential for effective disease management. The present study aims to minimize the rapid breakdown of disease resistance and in a way that limit the emergence of new races. Virulence screening on a set of rice differentials revealed the presence of 18 International races collected from various cultivars across three agroclimatic zones of Telangana, India. Further, 40 single spore isolates of <i>M. oryzae</i> were characterized using PCR-based genetic techniques such as RAPD, SSR, and Pot2-TIR. Notably, Lineage - I identified through Pot2 - TIR analysis contained the largest number of isolates, while other lineages represent smaller numbers of isolates. In broader terms, each lineage included isolates with different geographic origins, cultivars and diseased plant parts and there was no discernible relationship between pathotypes and DNA fingerprinting. Having been contemplated, these findings demonstrated that the <i>M. oryzae</i> population collected from various rice cultivars grown in Telangana had greater individual diversity than population diversity. Hence, for efficient disease management, use of certified seed and removal of collateral hosts are recommended.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04610-0.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"8"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-08DOI: 10.1007/s13205-025-04611-z
G Koteswara Reddy, Yuvaraj Dinakarkumar, Korukonda Satwik, Allam Sai Sree Thanay, Bobba Devi Sri Siddhartha, Nandigum Sai Anvesh, Selvaraj Arokiyaraj, Panneerselvam Theivendren
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease involving dysregulated matrix metalloproteinase-9 (MMP9) activity, leading to excessive extracellular matrix deposition and lung tissue deterioration. This study investigated bioactive compounds from Mentha piperita L. as potential MMP9 inhibitors for IPF therapy. Gas chromatography-mass spectrometry (GC-MS) analysis identified nine phytochemicals in the methanolic extract of peppermint leaves. Drug-likeness screening using Lipinski's Rule of Five identified two lead compounds: (-)-carvone and cis-dihydrocarvone. ADMET analysis revealed favorable pharmacokinetic properties, including appropriate solubility (-3.089 and -3.12, respectively) and blood-brain barrier permeability values (0.345 and 0.357). TOPKAT toxicity prediction classified both compounds as non-carcinogenic with negligible skin sensitization potential. Molecular docking against MMP9 (PDB ID: 1GKD) yielded MolDock scores of -84.22 for (-)-carvone and -87.47 for cis-dihydrocarvone, indicating strong binding affinity. Molecular dynamics simulations over 100 ns demonstrated stable protein-ligand complexes with consistent RMSD values (~ 0.8 Å for ligand), sustained hydrogen bonding interactions, and minimal conformational changes. Key residues LEU188, VAL398, HIS401, and TYR423 were identified as critical for binding stability. These computational findings establish (-)-carvone and cis-dihydrocarvone as promising MMP9 inhibitor candidates for IPF treatment, warranting in vitro and in vivo experimental validation.
{"title":"Molecular dynamics simulation and structural characterization of (-)-carvone and cis-dihydrocarvone from <i>Mentha piperita</i> L. as potential MMP9 inhibitors for idiopathic pulmonary fibrosis therapy.","authors":"G Koteswara Reddy, Yuvaraj Dinakarkumar, Korukonda Satwik, Allam Sai Sree Thanay, Bobba Devi Sri Siddhartha, Nandigum Sai Anvesh, Selvaraj Arokiyaraj, Panneerselvam Theivendren","doi":"10.1007/s13205-025-04611-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04611-z","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease involving dysregulated matrix metalloproteinase-9 (MMP9) activity, leading to excessive extracellular matrix deposition and lung tissue deterioration. This study investigated bioactive compounds from <i>Mentha piperita</i> L. as potential MMP9 inhibitors for IPF therapy. Gas chromatography-mass spectrometry (GC-MS) analysis identified nine phytochemicals in the methanolic extract of peppermint leaves. Drug-likeness screening using Lipinski's Rule of Five identified two lead compounds: (-)-carvone and cis-dihydrocarvone. ADMET analysis revealed favorable pharmacokinetic properties, including appropriate solubility (-3.089 and -3.12, respectively) and blood-brain barrier permeability values (0.345 and 0.357). TOPKAT toxicity prediction classified both compounds as non-carcinogenic with negligible skin sensitization potential. Molecular docking against MMP9 (PDB ID: 1GKD) yielded MolDock scores of -84.22 for (-)-carvone and -87.47 for cis-dihydrocarvone, indicating strong binding affinity. Molecular dynamics simulations over 100 ns demonstrated stable protein-ligand complexes with consistent RMSD values (~ 0.8 Å for ligand), sustained hydrogen bonding interactions, and minimal conformational changes. Key residues LEU188, VAL398, HIS401, and TYR423 were identified as critical for binding stability. These computational findings establish (-)-carvone and cis-dihydrocarvone as promising MMP9 inhibitor candidates for IPF treatment, warranting in vitro and in vivo experimental validation.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"9"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-08DOI: 10.1007/s13205-025-04635-5
Ping Jiang, Mingke Lian, Guiyu Liu, Pengfei Gu
5-aminolevulinic acid (5-ALA) is a naturally occurring, functional, non-protein amino acid that is ubiquitously present in biological cells, including microorganisms, plants, and animals. It functions as a key precursor in the biosynthesis of tetrahydropyrrole compounds in organisms. Due to its biodegradable, non-toxic, and residue-free properties, 5-ALA has been extensively utilized in medicine, agriculture, and animal production. In recent years, rapid advances in biotechnology have intensified interest in the biological synthesis of 5-ALA. This review provides a comprehensive summary of recent developments in microbial 5-ALA production via the C4 or C5 pathway, including engineering of key enzymes, enhancing the supply of precursors and cofactors, engineering product transporters, reducing by-product generation, dynamic regulation based on biosensors, and utilization of omics technology. These technologies have enabled the production of 5-ALA using bacteria, thereby significantly promoting the industrialization of 5-ALA synthesis. In addition, this review addresses the current challenges associated with the biological synthesis of 5-ALA and proposes prospects that offer guidance for its biosynthesis and industrial production.
{"title":"Recent advances in microbial production of 5-aminolevulinic acid by metabolic engineering.","authors":"Ping Jiang, Mingke Lian, Guiyu Liu, Pengfei Gu","doi":"10.1007/s13205-025-04635-5","DOIUrl":"https://doi.org/10.1007/s13205-025-04635-5","url":null,"abstract":"<p><p>5-aminolevulinic acid (5-ALA) is a naturally occurring, functional, non-protein amino acid that is ubiquitously present in biological cells, including microorganisms, plants, and animals. It functions as a key precursor in the biosynthesis of tetrahydropyrrole compounds in organisms. Due to its biodegradable, non-toxic, and residue-free properties, 5-ALA has been extensively utilized in medicine, agriculture, and animal production. In recent years, rapid advances in biotechnology have intensified interest in the biological synthesis of 5-ALA. This review provides a comprehensive summary of recent developments in microbial 5-ALA production via the C4 or C5 pathway, including engineering of key enzymes, enhancing the supply of precursors and cofactors, engineering product transporters, reducing by-product generation, dynamic regulation based on biosensors, and utilization of omics technology. These technologies have enabled the production of 5-ALA using bacteria, thereby significantly promoting the industrialization of 5-ALA synthesis. In addition, this review addresses the current challenges associated with the biological synthesis of 5-ALA and proposes prospects that offer guidance for its biosynthesis and industrial production.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"19"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}